Product Information
IBUPROFEN-FAMOTIDIN 800-26.6 MG is a generic product labeled by Ascend Laboratories, LLC, priced at $0.9449 per EA under NDC 67877062690. Its NADAC has been published 227 times since Feb 23, 2022.
Strength
26.6; 800 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877062690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FAMOTIDINE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA211890On Market Since
8/4/2021
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has been published 227 times since Feb 23, 2022, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9449 per EA |
|---|---|
| All-time high | $4.1664 (Nov 16, 2022) |
| All-time low | $0.6418 (Feb 18, 2026) |
| 52-week high | $1.0292 |
| 52-week low | $0.6418 |
| Median price | $1.6750 |
| Average price | $2.0913 |
| Largest weekly change | +71.1% (Aug 23, 2023) |
| Weeks tracked | 227 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN-FAMOTIDIN 800-26.6 MG?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN-FAMOTIDIN 800-26.6 MG, manufactured by Ascend Laboratories, LLC, is $0.9449 per EA (NDC 67877062690), effective Jun 24, 2026.
How has the price of IBUPROFEN-FAMOTIDIN 800-26.6 MG changed over time?
Over the history we have for it, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has declined 75.2%. It has been tracked across 227 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN-FAMOTIDIN 800-26.6 MG?
Since Feb 23, 2022, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has ranged from a low of $0.6418 (Feb 18, 2026) to a high of $4.1664 (Nov 16, 2022), with a median of $1.6750 per EA.
Are there cheaper alternatives to IBUPROFEN-FAMOTIDIN 800-26.6 MG?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IBUPROFEN-FAMOTIDIN 800-26.6 MG, but none are currently priced below it.
Who manufactures IBUPROFEN-FAMOTIDIN 800-26.6 MG?
IBUPROFEN-FAMOTIDIN 800-26.6 MG (NDC 67877062690) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification